Synlogic

$3.33
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 6:03 PM UTC today

Why Robinhood?

You can buy or sell Synlogic and other stocks, options, and ETFs commission-free!

About SYBX

Synlogic, Inc. engages in the discovery and development of Synthetic Biotic medicines. It focuses in Phenylketonuria, Enteric Hyperoxaluria, Immuno Oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs.

CEO

Aoife M. Brennan

Employees

Headquarters

Cambridge, Massachusetts

Founded

2017

Market Cap

139.18M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

774.83K

High Today

$3.40

Low Today

$3.27

Open Price

$3.38

Volume

171.55K

52 Week High

$5.11

52 Week Low

$1.74

Analyst Ratings

86%

of 7 ratings

Buy

86%

Hold

14%

Sell

SYBX Earnings

-$0.48

-$0.32

-$0.16

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 7, Pre-Market